|
Volumn , Issue 3, 2003, Pages
|
Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALITRETINOIN;
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
LIPOSOME;
RETINOIC ACID;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KAPOSI SARCOMA;
META ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SKIN TUMOR;
VIROLOGY;
ANTINEOPLASTIC AGENTS;
DOXORUBICIN;
HIV INFECTIONS;
HUMANS;
LIPOSOMES;
RANDOMIZED CONTROLLED TRIALS;
SARCOMA, KAPOSI;
SKIN NEOPLASMS;
TRETINOIN;
|
EID: 0141724788
PISSN: None
EISSN: 1469493X
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (32)
|
References (26)
|